(Q39497850)

12 September 2017

title

Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis (English)

1 reference

12 September 2017

1 reference

1 reference

2

1 reference

12 September 2017

Anna Vinarskaja

1

1 reference

12 September 2017

Marc Ingenwerth

series ordinal

3

1 reference

12 September 2017

Christiane Hader

series ordinal

4

1 reference

12 September 2017

Christian Arsov

series ordinal

5

1 reference

12 September 2017

publication date

30 July 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

31

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

622-627

1 reference

National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Natural history of localised prostatic cancer. A population-based study in 223 untreated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Hypermethylation of genes for diagnosis and risk stratification of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaborati

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.04.010

10.1016/J.UROLONC.2011.04.010

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference